Investigational Injectable Drug Demonstrates Efficacy in Localized Fat Reduction
Participants experienced an average reduction of 28.1% of subcutaneous fat volume compared with placebo.
Participants experienced an average reduction of 28.1% of subcutaneous fat volume compared with placebo.
A UK clinical study will evaluate Spectral AI’s DeepView System in anatomically complex burn areas, with a burns and plastic surgeon leading the first study site.